Share: Share on Facebook Share on Twitter Share on LinkedIn I recommend visiting to read:%0A%0A {0} %0A%0A {1}
Boston-BioBeat-Q4-2023-Hero-Image-3 Boston-BioBeat-Q4-2023-Mobile-Hero

​​Boston BioBeat February 2024 ​

Riley McMullan • 2/23/2024
Nearly 25% of Greater Boston’s life science inventory is currently available for lease, marking the first time in recorded market history that availability has surpassed 20.0%. The increase in availability was geographically widespread as each of the market’s five clusters recorded a quarter-over-quarter increase of at least 250 bps.  

The market hit a new historical high for construction deliveries in 2023 as nearly 6.7 msf of new lab inventory completed construction, 62.2% of which remains available. As the voracious demand that fueled the recent record-breaking bout of development has waned, construction starts have begun to slow, which will allow supply and demand to once again rebalance throughout the coming years.  

Greater Boston’s life science market continued its reign as one of the nation’s leading recipients for venture capital investment, topping the list in 2023 as the market received $6B, exceeding the next highest market’s total by more than $1B.  

Annual demand in 2023 was muted compared to historical averages, totaling 2.1 msf, as market conditions began to normalize following a sustained period of growth. Notably, emerging clusters have begun to claim an increasing share of leasing activity, with the 128 Central submarket surpassing East Cambridge’s annual total by 5.3%. Despite softening market conditions, Boston’s international reputation as a premiere life sciences market will keep it well-insulated from the worst effects of a slowdown. 
Insights in your Inbox
Subscribe to the latest local market research, insights and analysis from Cushman & Wakefield across the United States.

Related Insights

Boston Downtown Waterway at Dusk

Boston/Southern New Hampshire

Cushman & Wakefield MarketBeat reports analyze quarterly economic and commercial real estate activity including supply, demand and pricing trends at the market and submarket levels.
Riley McMullan • 4/11/2024
life sciences funding in view

​​Life Sciences Funding in View​

Global life sciences venture capital funding has reverted to its pre-pandemic long-term trend.
Sandy Romero • 1/29/2024
boston life sciences

​​Boston Life Sciences Market Trends​

Current Boston market conditions have created a unique moment in time that will greatly benefit life sciences occupiers and help Greater Boston sustain its healthy life sciences market.
Riley McMullan • 10/10/2023

Ready to talk?

Our professionals are ready to provide further details on this and many other topics.

With your permission we and our partners would like to use cookies in order to access and record information and process personal data, such as unique identifiers and standard information sent by a device to ensure our website performs as expected, to develop and improve our products, and for advertising and insight purposes.

Alternatively click on More Options and select your preferences before providing or refusing consent. Some processing of your personal data may not require your consent, but you have a right to object to such processing.

You can change your preferences at any time by returning to this site or clicking on  Cookies

More Options
Agree and Close
These cookies ensure that our website performs as expected,for example website traffic load is balanced across our servers to prevent our website from crashing during particularly high usage.
These cookies allow our website to remember choices you make (such as your user name, language or the region you are in) and provide enhanced features. These cookies do not gather any information about you that could be used for advertising or remember where you have been on the internet.
These cookies allow us to work with our marketing partners to understand which ads or links you have clicked on before arriving on our website or to help us make our advertising more relevant to you.
Agree All
Reject All